How Much Do GLP-1 Medications Cost? Insurance, HSA, and Savings Guide

The Real Cost of GLP-1 Medications

The sticker price of brand-name GLP-1 medications is one of the most significant barriers to access in the United States. Wegovy® (semaglutide 2.4mg for weight management) costs $1,300-$1,600 per month without insurance. Zepbound® (tirzepatide for weight management) costs $1,050-$1,400 per month. Compounded alternatives through a licensed telehealth provider cost $150-$350 per month for semaglutide or $200-$400 for tirzepatide — a savings of over $1,000 per month. See AvataCore pricing →

Does Insurance Cover GLP-1 Medications?

Medicare

As of 2026, Medicare Part D covers semaglutide (Wegovy) for patients with established cardiovascular disease following a landmark 2024 policy change driven by the SELECT trial. Coverage for weight loss without cardiovascular disease remains limited under Medicare.

Medicaid

Coverage varies by state. Some states cover GLP-1 medications for obesity; others restrict coverage to diabetes indications only.

Employer-Sponsored Insurance

This is the most variable category. Some large employers cover GLP-1 medications for obesity; many do not, citing high costs. Check your Summary of Benefits and Coverage (SBC) or call your plan's pharmacy benefits line.

The Reality Check

Most Americans with commercial insurance do not have coverage for GLP-1 medications specifically for weight loss. Even when coverage exists, prior authorization requirements, step therapy protocols, and high co-pays create substantial barriers.

HSA and FSA: Your Tax-Advantaged Option

If you have a Health Savings Account (HSA) or Flexible Spending Account (FSA), you can use pre-tax dollars to pay for GLP-1 medications and telehealth visits when prescribed by a licensed healthcare provider. This effectively reduces your out-of-pocket cost by your marginal tax rate. For someone in the 22% federal tax bracket, a $300/month program costs about $234/month in after-tax dollars.

What qualifies:

• Prescription medications (compounded semaglutide/tirzepatide qualify)
• Telehealth consultation fees
• Provider visit fees
• Lab work ordered by your provider

Manufacturer Savings Programs

Novo Nordisk and Eli Lilly offer co-pay savings cards for commercially insured patients, with eligible patients potentially paying as little as $25/month. However, these programs exclude Medicare, Medicaid, and uninsured patients.

Why Compounded GLP-1 Is the Most Accessible Option

For the majority of Americans who do not have insurance coverage for weight-loss GLP-1 medications, compounded semaglutide or tirzepatide through a licensed telehealth provider is the most practical path. At 15-25% of the cost of brand-name medications, compounded options have made GLP-1 treatment accessible to millions of people.

Annual comparison: Brand-name Wegovy without insurance costs $15,600-$19,200 per year. Compounded semaglutide via AvataCore costs $1,800-$4,200 per year — a savings of $10,000-$15,000 annually.